FR2122529A1 - Peptide, polypeptide protein complexes with silicon cpds - with delayed and/or increased biological activity - Google Patents

Peptide, polypeptide protein complexes with silicon cpds - with delayed and/or increased biological activity

Info

Publication number
FR2122529A1
FR2122529A1 FR7201789A FR7201789A FR2122529A1 FR 2122529 A1 FR2122529 A1 FR 2122529A1 FR 7201789 A FR7201789 A FR 7201789A FR 7201789 A FR7201789 A FR 7201789A FR 2122529 A1 FR2122529 A1 FR 2122529A1
Authority
FR
France
Prior art keywords
cpds
peptide
delayed
biological activity
protein complexes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7201789A
Other languages
English (en)
Other versions
FR2122529B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Nyrt
Richter Gedeon Vegyeszeti Gyar Nyrt
Original Assignee
Richter Gedeon Nyrt
Richter Gedeon Vegyeszeti Gyar RT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt, Richter Gedeon Vegyeszeti Gyar RT filed Critical Richter Gedeon Nyrt
Publication of FR2122529A1 publication Critical patent/FR2122529A1/fr
Application granted granted Critical
Publication of FR2122529B1 publication Critical patent/FR2122529B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/14—Enzymes or microbial cells immobilised on or in an inorganic carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/085—Angiotensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A61K38/35—Corticotropin [ACTH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/52—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
FR7201789A 1971-01-20 1972-01-19 Peptide, polypeptide protein complexes with silicon cpds - with delayed and/or increased biological activity Granted FR2122529A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HURI000418 1971-01-20

Publications (2)

Publication Number Publication Date
FR2122529A1 true FR2122529A1 (en) 1972-09-01
FR2122529B1 FR2122529B1 (fr) 1975-12-26

Family

ID=11000857

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7201789A Granted FR2122529A1 (en) 1971-01-20 1972-01-19 Peptide, polypeptide protein complexes with silicon cpds - with delayed and/or increased biological activity

Country Status (10)

Country Link
AU (1) AU3784072A (fr)
BE (1) BE778239A (fr)
CA (1) CA972288A (fr)
DD (1) DD98915A5 (fr)
DE (1) DE2202176A1 (fr)
ES (1) ES399033A1 (fr)
FR (1) FR2122529A1 (fr)
IL (1) IL38546A0 (fr)
NL (1) NL7200716A (fr)
ZA (1) ZA72252B (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2202678A1 (fr) * 1972-10-12 1974-05-10 Takeda Chemical Industries Ltd
FR2395026A1 (fr) * 1977-03-30 1979-01-19 Benzon As Alfred Dose medicamenteuse a unites multiples
EP0101027A1 (fr) * 1982-08-18 1984-02-22 Herbert Prof. Dr. Rupprecht Composés organiques liés à un support de silice, procédé de leur préparation et leur emploi
EP0189107A2 (fr) * 1985-01-23 1986-07-30 Dieter Aderhold Compositions thérapeutiques contenant des peptides et/ou des amino-acides
EP0398619A2 (fr) * 1989-05-16 1990-11-22 Ethicon, Inc. Compositions stabilisées contenant le facteur de croissance épidermique
EP1092728A2 (fr) * 1999-10-15 2001-04-18 Exsymol S.A.M. Complexe à base d'acide orthosilicique biologiquement assimilable, se présentant sous forme solide, stable et concentrée, et procédé de préparation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2202678A1 (fr) * 1972-10-12 1974-05-10 Takeda Chemical Industries Ltd
FR2395026A1 (fr) * 1977-03-30 1979-01-19 Benzon As Alfred Dose medicamenteuse a unites multiples
EP0101027A1 (fr) * 1982-08-18 1984-02-22 Herbert Prof. Dr. Rupprecht Composés organiques liés à un support de silice, procédé de leur préparation et leur emploi
EP0189107A2 (fr) * 1985-01-23 1986-07-30 Dieter Aderhold Compositions thérapeutiques contenant des peptides et/ou des amino-acides
EP0189107A3 (fr) * 1985-01-23 1987-09-02 Dieter Aderhold Compositions thérapeutiques contenant des peptides et/ou des amino-acides
EP0398619A2 (fr) * 1989-05-16 1990-11-22 Ethicon, Inc. Compositions stabilisées contenant le facteur de croissance épidermique
EP0398619A3 (fr) * 1989-05-16 1991-04-03 Ethicon, Inc. Compositions stabilisées contenant le facteur de croissance épidermique
EP1092728A2 (fr) * 1999-10-15 2001-04-18 Exsymol S.A.M. Complexe à base d'acide orthosilicique biologiquement assimilable, se présentant sous forme solide, stable et concentrée, et procédé de préparation
FR2799758A1 (fr) * 1999-10-15 2001-04-20 Exsymol Sa Complexe a base d'acide orthosilicique biologiquement assimilable, se presentant sous forme solide, stable et concentree, et procede de preparation
EP1092728A3 (fr) * 1999-10-15 2001-12-05 Exsymol S.A.M. Complexe à base d'acide orthosilicique biologiquement assimilable, se présentant sous forme solide, stable et concentrée, et procédé de préparation
US6335457B1 (en) 1999-10-15 2002-01-01 Exsymol S.A.M. Complex containing biologically assimilable orthosilicic acid, which is under solid form, stable and concentrated, and a process for preparation of said complex

Also Published As

Publication number Publication date
NL7200716A (fr) 1972-07-24
DE2202176A1 (de) 1972-08-03
DD98915A5 (fr) 1973-07-12
ES399033A1 (es) 1975-05-16
AU3784072A (en) 1973-07-19
IL38546A0 (en) 1972-03-28
BE778239A (fr) 1972-05-16
CA972288A (en) 1975-08-05
FR2122529B1 (fr) 1975-12-26
ZA72252B (en) 1972-09-27

Similar Documents

Publication Publication Date Title
BG104828A (en) Fap alpha-specific antibody with improved pruducibility
PT87138A (pt) Process for the preparation of adn recombinant molecules codin g polypeptide adn segments and of antibody compositions relate d with human tissue factor
ATE124959T1 (de) Herstellung und verwendung von nicht- glycosiliertem il-6.
ATE49233T1 (de) Vektoren zur transformation von hefe.
DE3650751T2 (de) Antikörper gegen Saugetier-Interleukin-4 und Peptide verwendbar als Antigenen für deren Herstellung
BR9406993A (pt) Microesferas de gases insolúveis encapsulados com proteína e sua preparação e uso como agentes de imagem ultrassônica
ATE312844T1 (de) Biologisch-aktive bakterizide/permeabilitätserhöhende proteinbruchstücke
FI954978A0 (fi) Modifioidut proteiini- ja peptidilääkeaineet
SE9101433D0 (sv) Recombinant dna sequence and its use
AU4293189A (en) Process for the activation of gene-technologically produced, biologically-active proteins expressed in prokaryotes
FR2122529A1 (en) Peptide, polypeptide protein complexes with silicon cpds - with delayed and/or increased biological activity
ATE144535T1 (de) Plättchen blockierende peptide
AU472647B2 (en) N-protected amino acids and peptides
ATE410514T1 (de) Calciumbindende rekombinante antikörper gegen protein c
PL364771A1 (en) Lantibiotic
ATE225806T1 (de) D-2-alkyltryptophan enthaltende polypeptide mit wachstumhormon freisetzender aktivitaet
HU9402575D0 (en) Delivery and expression on a hybrid supface protein on the suprale of gram positive bacteria
DK288789A (da) Peptider og syreadditionssalte deraf, deres fremstilling og anvendelse
NO881904D0 (no) Fremgangsmaate til selektiv immunologisk bestemmelse av intakt prokollagen peptid (type iii) og prokollagen (type iii) i kroppsvaesker, og middel til dets gjennomfoering.
DK0639225T3 (da) Nye polypeptider og peptider, nucleinsyrer, der koder for dem, og deres anvendelse i området tumorterapi, inflammation eller immunologi
DE3881123D1 (de) Klonieren von fuer einen antibakteriellen polypeptidvorlaeufer kodierender dna und expression des vorlaeufers.
FR2241257A1 (en) Utilisation of keratin as amino-nitrogen source - for foodstuffs, by breakdown to protein, peptides and amino acids
ATE82754T1 (de) Sorbin und abgeleitete peptide, die die absorption durch die mucosa erhoehen.
ATE92333T1 (de) Arzneimittel zur intralesionsbehandlung von schuppenartigem zellkarzinomen mit rekombinantem human-alpha-interferon.
SE401956B (sv) Anvendning av med protein eller peptid polystyrenlatex som diagnostiskt reagens

Legal Events

Date Code Title Description
ST Notification of lapse